alfuzosin hydrochloride
SpainDrugs containing this active substance
-
It is used to treat moderate to severe symptoms of benign prostatic hyperplasia (a non-cancerous enlargement of the prostate). It can also help restore urine flow in men over 65 years of age suffering from acute urinary retention.
Form: tablets, prolonged-release
Active substance Dosage alfuzosin hydrochloride 10 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used to treat the symptoms of benign prostatic hyperplasia (a non-cancerous enlargement of the prostate that makes it difficult for urine to pass). It can also be used to help urine flow again in cases of acute urinary retention.
Form: tablets, prolonged-release
Active substance Dosage alfuzosin hydrochloride 10,0 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to treat moderate to severe symptoms caused by an enlarged prostate (benign prostatic hyperplasia), such as difficulty urinating or the need to urinate frequently, especially at night.
Form: tablets, prolonged-release
Active substance Dosage alfuzosin hydrochloride 10,00 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat symptoms caused by an enlarged prostate (benign prostatic hyperplasia), which can cause problems urinating or the need to urinate frequently.
Form: tablets, prolonged-release
Active substance Dosage alfuzosin hydrochloride 10 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to treat moderate to severe symptoms caused by an enlarged prostate (benign prostatic hyperplasia), such as difficulty urinating or the frequent urge to urinate. It can also help urine flow again in cases of acute urinary retention.
Form: tablets, prolonged-release
Active substance Dosage alfuzosin hydrochloride 10,0 mg Manufacturer: Viatris Limited
-
It is used to treat the functional symptoms of benign prostatic hyperplasia (enlarged prostate).
Form: tablets, prolonged-release
Active substance Dosage alfuzosin hydrochloride 5 mg Manufacturer: Sanofi Aventis S.A.
-
It is used to treat the functional symptoms of benign prostatic hyperplasia (enlarged prostate).
Form: tablets, prolonged-release
Active substance Dosage alfuzosin hydrochloride 10,00 mg Manufacturer: Sanofi Aventis S.A.